Trial intelligence / Profile preview

Tranexamic Acid for Blood Loss in Vaginal Hysterectomy

NCT05921071Recruiting

Sponsor
Edith Wolfson Medical Center
Start
Jan 2023
Primary completion
Jun 2024
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial in pelvic organ prolapse (POP) comparing Tranexamic acid arm with Placebo arm (2 arms). Primary endpoint: Mean objective assessment of blood loss. Started Jan 2023; status: recruiting.

02

Drugs

tranexamic acid
03

Conditions

pelvic organ prolapse (POP)

Beyond the preview

Go deeper on NCT05921071.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05921071.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call